Search results
For Cipla, repeated US FDA observations are a cause of concern
Livemint· 2 hours agoYet, an adverse report on the third successive inspection of the Goa plant affects its credibility....
Emcure Pharmaceuticals to Launch IPO on July 3 with Price Band of Rs 960-1008 | India Infoline
India Infoline· 5 hours agoPune-based Emcure Pharmaceuticals is gearing up to launch its maiden public issue for subscription on July 3. The company has set a price band of ₹960-1008 per share ...
Emcure Pharmaceuticals IPO to hit Dalal Street on July 3
CNBC Awaaz· 24 hours agoEmcure Pharmaceuticals IPO is a mix of fresh issuance of equity shares worth Rs 800 crore, and an...
Trade Setup for June 28: Nifty set for best month of 2024 after conquering 24,000 - CNBC TV18
CNBC TV18· 19 hours agoThe Nifty is up nearly 7% in the month of June, which will be the best month for the index since...